Home » Array Drug Misses Study Goal
Array Drug Misses Study Goal
Shares of Array BioPharma Inc. tumbled in premarket trading Friday after the drugmaker said its experimental rheumatoid arthritis treatment didn’t prove more effective than a placebo in reducing symptoms in a midstage study.
CNBC
CNBC
Upcoming Events
-
02May
-
07May
-
14May
-
23May
-
30May